Literature DB >> 8627790

Identification of amino acids involved in recognition by dengue virus NS3-specific, HLA-DR15-restricted cytotoxic CD4+ T-cell clones.

L Zeng1, I Kurane, Y Okamoto, F A Ennis, M A Brinton.   

Abstract

The majority of T-cell clones derived from a donor who experienced dengue illness following receipt of a live experimental dengue virus type 3 (DEN3) vaccine cross-reacted with all four serotypes of dengue virus, but some were serotype specific or only partially cross-reactive. The nonstructural protein, NS3, was immuno-dominant in the CD4+ T-cell response of this donor. The epitopes of four NS3-specific T-cell clones were analyzed. JK15 and JK13 recognized only DEN3 NS3, while JK44 recognized DEN1, DEN2, and DEN3 NS3 and JK5 recognized DEN1, DEN3, and West Nile virus NS3. The epitopes recognized by these clones on the DEN3 NS3 protein were localized with recombinant vaccinia viruses expressing truncated regions of the NS3 gene, and then the minimal recognition sequence was mapped with synthetic peptides. Amino acids critical for T-cell recognition were assessed by using peptides with amino acid substitutions. One of the serotype-specific clones (JK13) and the subcomplex- and flavivirus-cross-reactive clone (JK5) recognized the same core epitope, WITDFVGKTVW. The amino acid at the sixth position of this epitope is critical for recognition by both clones. Sequence analysis of the T-cell receptors of these two clones showed that they utilize different VP chains. The core epitopes for the four HLA-DR15-restricted CD4+ CTL clones studied do not contain motifs similar to those proposed by previous studies on endogenous peptides eluted from HLA-DR15 molecules. However, the majority of these dengue virus NS3 core epitopes have a positive amino acid (K or R) at position 8 or 9. Our results indicate that a single epitope can induce T cells with different virus specificities despite the restriction of these T cells by the same HLA-DR15 allele. This finding suggests a previously unappreciated level of complexity for interactions between human T-cell receptors and viral epitopes with very similar sequences on infected cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627790      PMCID: PMC190173     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  The nucleotide sequence of dengue type 4 virus: analysis of genes coding for nonstructural proteins.

Authors:  E Mackow; Y Makino; B T Zhao; Y M Zhang; L Markoff; A Buckler-White; M Guiler; R Chanock; C J Lai
Journal:  Virology       Date:  1987-08       Impact factor: 3.616

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

3.  Dengue virus-specific murine T-lymphocyte proliferation: serotype specificity and response to recombinant viral proteins.

Authors:  A L Rothman; I Kurane; Y M Zhang; C J Lai; F A Ennis
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

4.  Sequence analysis of cloned dengue virus type 2 genome (New Guinea-C strain).

Authors:  K Irie; P M Mohan; Y Sasaguri; R Putnak; R Padmanabhan
Journal:  Gene       Date:  1989-02-20       Impact factor: 3.688

5.  Presentation of an immunodominant T-cell epitope of hepatitis B surface antigen by the HLA-DPw4 molecule.

Authors:  E Celis; R W Karr
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

6.  General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.

Authors:  M Mackett; G L Smith; B Moss
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

Review 7.  Pathogenesis of dengue: challenges to molecular biology.

Authors:  S B Halstead
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production.

Authors:  I Kurane; B L Innis; A Nisalak; C Hoke; S Nimmannitya; A Meager; F A Ennis
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

10.  A single nine-amino acid peptide induces virus-specific, CD8+ human cytotoxic T lymphocyte clones of heterogeneous serotype specificities.

Authors:  J Zivny; I Kurane; A M Leporati; M Ibe; M Takiguchi; L L Zeng; M A Brinton; F A Ennis
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

View more
  27 in total

1.  Chimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response.

Authors:  R G van Der Most; K Murali-Krishna; R Ahmed; J H Strauss
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections.

Authors:  Cameron P Simmons; Tao Dong; Nguyen Vinh Chau; Nguyen Thi Phuong Dung; Tran Nguyen Bich Chau; Le Thi Thu Thao; Nguyen Thi Dung; Tran Tinh Hien; Sarah Rowland-Jones; Jeremy Farrar
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

3.  A systematic bioinformatics approach for selection of epitope-based vaccine targets.

Authors:  Asif M Khan; Olivo Miotto; A T Heiny; Jerome Salmon; K N Srinivasan; Eduardo J M Nascimento; Ernesto T A Marques; Vladimir Brusic; Tin Wee Tan; J Thomas August
Journal:  Cell Immunol       Date:  2007-04-16       Impact factor: 4.868

4.  CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination.

Authors:  Lauren E Yauch; Tyler R Prestwood; Monica M May; Malika M Morar; Raphaël M Zellweger; Bjoern Peters; Alessandro Sette; Sujan Shresta
Journal:  J Immunol       Date:  2010-09-24       Impact factor: 5.422

5.  Clade replacements in dengue virus serotypes 1 and 3 are associated with changing serotype prevalence.

Authors:  Chunlin Zhang; Mammen P Mammen; Piyawan Chinnawirotpisan; Chonticha Klungthong; Prinyada Rodpradit; Patama Monkongdee; Suchitra Nimmannitya; Siripen Kalayanarooj; Edward C Holmes
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 6.  Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.

Authors:  Anuja Mathew; Elizabeth Townsley; Francis A Ennis
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

7.  Definition of amino acid residues on the epitope responsible for recognition by influenza A virus H1-specific, H2-specific, and H1- and H2-cross-reactive murine cytotoxic T-lymphocyte clones.

Authors:  M Tamura; K Kuwano; I Kurane; F A Ennis
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

8.  Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection.

Authors:  A Mathew; I Kurane; S Green; H A Stephens; D W Vaughn; S Kalayanarooj; S Suntayakorn; D Chandanayingyong; F A Ennis; A L Rothman
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

9.  Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a.

Authors:  A Mathew; I Kurane; A L Rothman; L L Zeng; M A Brinton; F A Ennis
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

10.  Molecular mechanism of pathogenesis of dengue virus: Entry and fusion with target cell.

Authors:  S K Jain
Journal:  Indian J Clin Biochem       Date:  2005-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.